News Sentiment

KMDA sentiment intelligence

Kamada news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 49 Balanced news tone 32 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 7.12 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

78/100 classification confidence.

Company focus 32

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

-5.1% over one week, -4.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Kamada (KMDA) Presents Promising Cytogam Study Results at Global Conference

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 78/100 classification
One-week reaction -5.1% Price reacting lower
Trend fit Trend inactive -4.3% over four weeks
Fair value 14.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 21
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 32
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 3
GlobeNewswire 3
DonanımHaber 3
GuruFocus 2
dars.gov.et 2
Zacks 2
Seeking Alpha 2
TradingView 1

Event Lens

What the news is about

Classified themes
Earnings 16
Market update 12
Regulatory and legal 2
Capital return 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 32
Associated Press Direct company coverage

Kamada: Q1 Earnings Snapshot

Tone
Neutral 50/100
Event
Earnings
Published
13 May 2026 11:13
Source
Associated Press